These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 31423730)

  • 21. High phosphate-induced downregulation of PPARγ contributes to CKD-associated vascular calcification.
    Liu L; Liu Y; Zhang Y; Bi X; Nie L; Liu C; Xiong J; He T; Xu X; Yu Y; Yang K; Gu J; Huang Y; Zhang J; Zhang Z; Zhang B; Zhao J
    J Mol Cell Cardiol; 2018 Jan; 114():264-275. PubMed ID: 29197521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NRF2-suppressed vascular calcification by regulating the antioxidant pathway in chronic kidney disease.
    Jin D; Lin L; Xie Y; Jia M; Qiu H; Xun K
    FASEB J; 2022 Jan; 36(1):e22098. PubMed ID: 34918390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-24 attenuates β-glycerophosphate-induced calcification of vascular smooth muscle cells by inhibiting apoptosis, the expression of calcification and osteoblastic markers, and the Wnt/β-catenin pathway.
    Lee KM; Kang HA; Park M; Lee HY; Choi HR; Yun CH; Oh JW; Kang HS
    Biochem Biophys Res Commun; 2012 Nov; 428(1):50-5. PubMed ID: 23063979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnesium inhibits Wnt/β-catenin activity and reverses the osteogenic transformation of vascular smooth muscle cells.
    Montes de Oca A; Guerrero F; Martinez-Moreno JM; Madueño JA; Herencia C; Peralta A; Almaden Y; Lopez I; Aguilera-Tejero E; Gundlach K; Büchel J; Peter ME; Passlick-Deetjen J; Rodriguez M; Muñoz-Castañeda JR
    PLoS One; 2014; 9(2):e89525. PubMed ID: 24586847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Interplay of WNT and PPARγ Signaling in Vascular Calcification.
    Reinhold S; Blankesteijn WM; Foulquier S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33322009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Inhibits Vascular Calcification Through Sirtuin 3-Mediated Reduction of Mitochondrial Oxidative Stress.
    Feng H; Wang JY; Yu B; Cong X; Zhang WG; Li L; Liu LM; Zhou Y; Zhang CL; Gu PL; Wu LL
    Antioxid Redox Signal; 2019 Jul; 31(1):75-91. PubMed ID: 30829051
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduction of Secreted Frizzled-Related Protein 5 Drives Vascular Calcification through Wnt3a-Mediated Rho/ROCK/JNK Signaling in Chronic Kidney Disease.
    Oh YJ; Kim H; Kim AJ; Ro H; Chang JH; Lee HH; Chung W; Jun HS; Jung JY
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermedin1‑47 inhibits high phosphate‑induced vascular smooth muscle cell calcification by regulating Wnt/β‑catenin signaling.
    Zhang Y; Tang N; Zhou J
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34414455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II prevents calcification in vascular smooth muscle cells by enhancing magnesium influx.
    Herencia C; Rodríguez-Ortiz ME; Muñoz-Castañeda JR; Martinez-Moreno JM; Canalejo R; Montes de Oca A; Díaz-Tocados JM; Peralbo-Santaella E; Marín C; Canalejo A; Rodriguez M; Almaden Y
    Eur J Clin Invest; 2015 Nov; 45(11):1129-44. PubMed ID: 26268950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromedin B modulates phosphate-induced vascular calcification.
    Park HJ; Kim MK; Kim Y; Kim HJ; Bae SK; Bae MK
    BMB Rep; 2021 Nov; 54(11):569-574. PubMed ID: 34674793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indoxyl sulfate accelerates vascular smooth muscle cell calcification via microRNA-29b dependent regulation of Wnt/β-catenin signaling.
    Zhang H; Chen J; Shen Z; Gu Y; Xu L; Hu J; Zhang X; Ding X
    Toxicol Lett; 2018 Mar; 284():29-36. PubMed ID: 29195902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Periostin Augments Vascular Smooth Muscle Cell Calcification via β-Catenin Signaling.
    Alesutan I; Henze LA; Boehme B; Luong TTD; Zickler D; Pieske B; Eckardt KU; Pasch A; Voelkl J
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BRCC36 prevents vascular calcification in chronic kidney disease through the β-catenin signalling pathway.
    Xie C; Chen C; Wu L; Xiong Y; Xing C; Mao H
    Exp Cell Res; 2022 Apr; 413(1):113051. PubMed ID: 35149088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roxadustat ameliorates vascular calcification in CKD rats by regulating HIF-2α/HIF-1α.
    Wang Y; Xiao M; Cai F; Li Y; Shi T; Zhou X; Tian S; Huang D
    Environ Toxicol; 2024 Apr; 39(4):2363-2373. PubMed ID: 38156404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cross-linked chitosan iron (III) on vascular calcification in uremic rats.
    de Castro BBA; do Carmo WB; de Albuquerque Suassuna PG; Carminatti M; Brito JB; Dominguez WV; de Oliveira IB; Jorgetti V; Custodio MR; Sanders-Pinheiro H
    Exp Biol Med (Maywood); 2018 May; 243(9):796-802. PubMed ID: 29763365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of crosstalk between endothelial cells and smooth muscle cells in vascular calcification in chronic kidney disease.
    Zhang YX; Tang RN; Wang LT; Liu BC
    Cell Prolif; 2021 Mar; 54(3):e12980. PubMed ID: 33502070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway.
    Liu X; Chen A; Liang Q; Yang X; Dong Q; Fu M; Wang S; Li Y; Ye Y; Lan Z; Chen Y; Ou JS; Yang P; Lu L; Yan J
    Aging Cell; 2021 Jun; 20(6):e13377. PubMed ID: 33969611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxidative stress contributes to vascular calcification in patients with chronic kidney disease.
    Huang M; Zheng L; Xu H; Tang D; Lin L; Zhang J; Li C; Wang W; Yuan Q; Tao L; Ye Z
    J Mol Cell Cardiol; 2020 Jan; 138():256-268. PubMed ID: 31866376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CKAP4 contributes to the progression of vascular calcification (VC) in chronic kidney disease (CKD) by modulating YAP phosphorylation and MMP2 expression.
    Shi Y; Jin X; Yang M; Jia J; Yao H; Yuan W; Wang K; Rong S
    Cell Signal; 2022 May; 93():110270. PubMed ID: 35108641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease.
    Zhou T; Zu G; Zhang X; Wang X; Li S; Gong X; Liang Z; Zhao J
    Neuropharmacology; 2016 Feb; 101():480-9. PubMed ID: 26525190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.